Palvella Therapeutics Inc... (PVLA)
NASDAQ: PVLA
· Real-Time Price · USD
22.16
-0.96 (-4.15%)
At close: May 14, 2025, 3:40 PM
-4.15% (1D)
| Bid | 22.16 |
| Market Cap | 244.77M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -9.25M |
| EPS (ttm) | -7.83 |
| PE Ratio (ttm) | -2.83 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 22.5 |
| Volume | 31,114 |
| Avg. Volume (20D) | 79,726 |
| Open | 23.36 |
| Previous Close | 23.12 |
| Day's Range | 22.16 - 24.19 |
| 52-Week Range | 6.20 - 29.27 |
| Beta | -23.17 |
About PVLA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PVLA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PVLA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-15.72%
Palvella Therapeutics shares are trading lower on ...
Unlock content with
Pro Subscription
3 months ago
+6.26%
Palvella Therapeutics shares are trading higher after TD Cowen initiated coverage on the stock with a Buy rating and announced a price target of $44.